Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Same-visit endoscopic ultrasound plus ERCP for pancreaticobiliary conditions

Official title: Effect of Same-session Endoscopic Ultrasonography on Endoscopic Retrograde Cholangiopancreatography in Pancreaticobiliary Diseases: A Randomized Controlled Trial

Run by Qilu Hospital of Shandong University · NCT06978231 · Data updated 2026-11-12

We will test whether doing endoscopic ultrasound (EUS) during the same visit as ERCP changes the procedure plan and improves outcomes for adults with pancreaticobiliary diseases.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment214 (estimated)
SponsorQilu Hospital of Shandong University
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Jinan, Shandong)
StatusRecruiting
StartedJune 10, 2025
Main results expectedDecember 2026
Study endsApril 2027
Registry record updatedSeptember 9, 2025
Trial IDNCT06978231 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older who are newly indicated for ERCP, have not had prior ERCP, and have not had pancreaticobiliary EUS within the past three months are ideal candidates.

Probably not a fit

Patients with unresectable malignancies needing only pathological confirmation, those requiring only palliative stenting, people with anatomy that prevents EUS, severe comorbid conditions, contrast allergy, or pregnancy are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center randomized controlled trial will enroll adults indicated for ERCP and randomize them 1:1 to same-session EUS plus ERCP versus ERCP alone. Clinical data and patient-reported outcomes are collected at baseline and during follow-up, and a structured questionnaire will record whether EUS changed the planned ERCP strategy. Secondary comparisons include complication rates, technical success, hospitalization costs, length of stay, and radiation exposure. Outcomes will be compared between groups to determine the safety and practical impact of adding same-session EUS.

Why it matters

Potential benefit: If successful, adding same-session EUS could help doctors choose better ERCP approaches during a single visit, potentially reducing complications, shortening hospital stays, and lowering radiation exposure and costs.

How similar studies have gone: Observational studies and small prospective reports indicate same-session EUS can alter management and appear safe, but randomized controlled data remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients aged ≥18 years;
2. Patients with pancreaticobiliary diseases definitively indicated for ERCP (as confirmed by HBP Specialists );
3. No prior history of ERCP;
4. No pancreaticobiliary EUS examinations within the preceding 3 months.

Exclusion Criteria:

1. Patients with clinically confirmed malignant lesions deemed surgically unresectable by multidisciplinary evaluation and requiring pathological diagnosis exclusively for chemotherapy/radiotherapy guidance;
2. Patients with confirmed diagnosis requiring only palliative biliary/pancreatic stent placement for obstructive jaundice ;
3. Patients with anatomical alterations or surgical history affecting EUS feasibility;
4. Severe systemic illness including severe hepatic, renal, cardiopulmonary and cerebrovascular diseases with high risk for endoscopic procedures;
5. Contraindication to iodinated contrast media (allergy or renal impairment preventing ERCP);
6. Pregnancy or lactation;
7. Patients with severe coagulopathy;
8. Declined informed consent;
9. Severe psychiatric disorder/non-cooperation precluding safe procedure.

Where it's running

  • Qilu Hospital of Shandong University
    Jinan, Shandong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.